• 1
    Ley, K., Laudanna, C., Cybulsky, M. I. and Nourshargh, S., Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007. 7: 678689.
  • 2
    Zarbock, A. and Ley, K., Mechanisms and consequences of neutrophil interaction with the endothelium. Am. J. Pathol. 2008. 172: 17.
  • 3
    Serhan, C. N., Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am. J. Pathol. 2010. 177: 15761591.
  • 4
    Reiss, K. and Saftig, P., The “a disintegrin and metalloprotease” (ADAM) family of sheddases: physiological and cellular functions. Semin. Cell Dev. Biol. 2009. 20: 126137.
  • 5
    Dominguez-Luis, M., Lamana, A., Vazquez, J., Garcia-Navas, R., Mollinedo, F., Sanchez-Madrid, F., Diaz-Gonzalez, F. and Urzainqui, A., The metalloprotease ADAM8 is associated with and regulates the function of the adhesion receptor PSGL-1 through ERM proteins. Eur. J. Immunol. 2011. 34363442.
  • 6
    Lichtenthaler, S. F., Dominguez, D. I., Westmeyer, G. G., Reiss, K., Haass, C., Saftig, P., De Strooper, B. and Seed, B., The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J. Biol. Chem. 2003. 278: 4871348719.
  • 7
    White, J. M., ADAMs: modulators of cell–cell and cell–matrix interactions. Curr. Opin. Cell Biol. 2003. 15: 598606.
  • 8
    Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J. et al., The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion. J. Biol. Chem. 2002. 277: 4821048219.
  • 9
    Gomez-Gaviro, M., Dominguez-Luis, M., Canchado, J., Calafat, J., Janssen, H., Lara-Pezzi, E., Fourie, A. et al., Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding. J. Immunol. 2007. 178: 80538063.
  • 10
    Fourie, A. M., Coles, F., Moreno, V. and Karlsson, L., Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J. Biol. Chem. 2003. 278: 3046930477.
  • 11
    Blobel, C. P., ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 2005. 6: 3243.
  • 12
    Choi, S. J., Han, J. H. and Roodman, G. D., ADAM8: a novel osteoclast stimulating factor. J. Bone Miner. Res. 2001. 16: 814822.
  • 13
    Schlomann, U., Rathke-Hartlieb, S., Yamamoto, S., Jockusch, H. and Bartsch, J. W., Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron–glia interactions during neurodegeneration. J. Neurosci. 2000. 20: 79647971.
  • 14
    Paulissen, G., Rocks, N., Gueders, M. M., Bedoret, D., Crahay, C., Quesada-Calvo, F., Hacha, J. et al., ADAM-8, a metalloproteinase, drives acute allergen-induced airway inflammation. Eur. J. Immunol. 2011. 41: 380391.
  • 15
    Xia, L., Sperandio, M., Yago, T., McDaniel, J. M., Cummings, R. D., Pearson-White, S., Ley, K. and McEver, R. P., P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J. Clin. Invest. 2002. 109: 939950.
  • 16
    Zarbock, A., Lowell, C. A. and Ley, K., Spleen tyrosine kinase Syk is necessary for E-selectin-induced α(L)β(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity 2007. 26: 773783.
  • 17
    Yago, T., Shao, B., Miner, J. J., Yao, L., Klopocki, A. G., Maeda, K., Coggeshall, K. M. and McEver, R. P., E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling. Blood 2010. 116: 485494.
  • 18
    Zarbock, A., Muller, H., Kuwano, Y. and Ley, K., PSGL-1-dependent myeloid leukocyte activation. J. Leukoc. Biol. 2009. 86: 11191124.
  • 19
    Matsuno, O., Miyazaki, E., Nureki, S., Ueno,T., Kumamoto, T. and Higuchi, Y., Role of ADAM8 in experimental asthma. Immunol. Lett. 2006. 102: 6773.
  • 20
    Alonso-Lebrero, J. L., Serrador, J. M., Dominguez-Jimenez, C., Barreiro, O., Luque, A., del Pozo, M. A., Snapp, K. et al., Polarization and interaction of adhesion molecules P-selectin glycoprotein ligand 1 and intercellular adhesion molecule 3 with moesin and ezrin in myeloid cells. Blood 2000. 95: 24132419.
  • 21
    Urzainqui, A., Serrador, J. M., Viedma, F., Yanez-Mo, M., Rodriguez, A., Corbi, A. L., Alonso-Lebrero, J. L. et al., ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1. Immunity 2002. 17: 401412.
  • 22
    Garton, K. J., Gough, P. J. and Raines, E. W., Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J. Leukoc. Biol. 2006. 79: 11051116.
  • 23
    Schulz, B., Pruessmeyer, J., Maretzky,T., Ludwig, A., Blobel,C. P., Saftig, P. and Reiss, K., ADAM10 regulates endothelial permeability and T-cell transmigration by proteolysis of vascular endothelial cadherin. Circ. Res. 2008. 102: 11921201.
  • 24
    Hundhausen, C., Misztela, D., Berkhout, T. A., Broadway, N., Saftig, P., Reiss, K., Hartmann, D. et al., The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003. 102: 11861195.
  • 25
    Tang, J., Zarbock, A., Gomez, I., Wilson, C. L., Lefort, C. T., Stadtmann, A., Bell, B. et al., Adam17-dependent shedding limits early neutrophil influx but does not alter early monocyte recruitment to inflammatory sites. Blood 2011. 118: 786794.
  • 26
    Long, C., Wang, Y., Herrera, A. H., Horiuchi, K. and Walcheck, B., In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis. J. Leukoc. Biol. 2010. 87: 10971101.
  • 27
    Opal, S. M. and DePalo, V. A., Anti-inflammatory cytokines. Chest 2000. 117: 11621172.
  • 28
    Kempf, T., Zarbock, A., Widera, C., Butz, S., Stadtmann, A., Rossaint, J., Bolomini-Vittori, M. et al., GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat. Med. 2011. 17: 581588.
  • 29
    Karan, D., Holzbeierlein, J. and Thrasher, J. B., Macrophage inhibitory cytokine-1: possible bridge molecule of inflammation and prostate cancer. Cancer Res. 2009. 69: 25.